Clozapine in the management of persistent destructive behaviour in a 17-year-old boy with intellectual disability

BMJ Case Rep. 2020 Nov 3;13(11):e235346. doi: 10.1136/bcr-2020-235346.

Abstract

The management of challenging and refractory destructive behaviour in young patients with intellectual disability (ID) is a major issue faced by families, carers and healthcare professionals who support them. Often, paediatricians and psychiatrists use various behavioural and psychopharmacological approaches, including polypharmacy. We report on one such patient who benefitted greatly from a trial of clozapine, resulting in less aggression, improved quality of life and potentially huge cost savings. We conclude that clozapine may represent a beneficial though seldom-used option for severe, destructive behaviour in young people with ID.

Keywords: child and adolescent psychiatry; developmental paediatrocs.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antipsychotic Agents / therapeutic use
  • Clozapine / therapeutic use*
  • Humans
  • Intellectual Disability / drug therapy*
  • Intellectual Disability / psychology
  • Male
  • Quality of Life*
  • Self-Injurious Behavior / drug therapy*
  • Self-Injurious Behavior / psychology

Substances

  • Antipsychotic Agents
  • Clozapine